- Home
- IGC vs IINN Comparison
IGC vs IINN Comparison
Compare IGC & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- IINN
- Stock Information
- Founded
- IGC 2005
- IINN 2018
- Country
- IGC United States
- IINN Israel
- Employees
- IGC N/A
- IINN N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- IGC Health Care
- IINN Health Care
- Exchange
- IGC Nasdaq
- IINN Nasdaq
- Market Cap
- IGC 39.8M
- IINN 34.1M
- IPO Year
- IGC N/A
- IINN 2021
- Fundamental
- Price
- IGC $0.42
- IINN $1.20
- Analyst Decision
- IGC Strong Buy
- IINN Strong Buy
- Analyst Count
- IGC 2
- IINN 1
- Target Price
- IGC $4.00
- IINN $2.00
- AVG Volume (30 Days)
- IGC 1.4M
- IINN 1.5M
- Earning Date
- IGC 08-14-2025
- IINN 09-19-2025
- Dividend Yield
- IGC N/A
- IINN N/A
- EPS Growth
- IGC N/A
- IINN N/A
- EPS
- IGC N/A
- IINN N/A
- Revenue
- IGC $1,327,000.00
- IINN N/A
- Revenue This Year
- IGC $15.26
- IINN N/A
- Revenue Next Year
- IGC $3.41
- IINN $2,050.00
- P/E Ratio
- IGC N/A
- IINN N/A
- Revenue Growth
- IGC 24.95
- IINN N/A
- 52 Week Low
- IGC $0.25
- IINN $0.40
- 52 Week High
- IGC $0.50
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- IGC 55.05
- IINN 50.05
- Support Level
- IGC $0.39
- IINN $1.11
- Resistance Level
- IGC $0.47
- IINN $1.23
- Average True Range (ATR)
- IGC 0.04
- IINN 0.08
- MACD
- IGC 0.00
- IINN -0.00
- Stochastic Oscillator
- IGC 43.67
- IINN 32.14
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.